Ginkgolides for inhibition of membrane expression of benzodiazepine receptors
AssigneeSociete de Conseils de Recherches et d'Applications Scientifiques
InventorKaty Drieu
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of ginkgolides and extracts of Ginkgo biloba for inhibiting the membrane expression of benzodiazepine receptors and for inhibiting the release of glucocorticoids in a patient.
Claims12
A method of inhibiting the membrane expression of a benzodiazepine receptor in a patient, said method comprising administering to said patient an effective amount of a ginkgolide.
A method of inhibiting the release of a glucocorticoid in a patient, said method comprising administering to said patient an effective amount of a ginkgolides or ginkgo biloba extracts capable of inhibiting the membrane expression of an adrenal benzodiazepine receptor.
Dependencies are inferred from the claim text.